Year: 2020
Type: article
Abstract: . Strikingly, these inhibitors acted in a bacteria-selective manner. These metabolic inhibitors will provide a platform for systematic study of bacterial glycosylation enzymes not currently possible with existing tools. Moreover, their selectivity will provide a pathway for the development of novel, narrow-spectrum antibiotics to treat infectious disease. Our inhibition approach is general and will expedite the identification of bacterial glycan biosynthesis inhibitors in a range of systems, expanding the glycochemistry toolkit.
Source: Chemical Science
DOI: 10.1039/c9sc05955e
Authors: Daniel A. Williams, Kabita Pradhan, Ankita Paul, Ilana R. Olin, Owen T. Tuck, Karen D. Moulton, Suvarn S. Kulkarni, Danielle H. Dube
Language: English
Subfield: Organic Chemistry
Field: Chemistry
Domain: Physical Sciences
Open Access status: diamond
OpenAlex ID: W2999046098
